Impact of the Race-Neutral Equation on Mortality Risk Prediction in Korean Patients With Chronic Obstructive Pulmonary Disease
- PMID: 40611600
- DOI: 10.1111/resp.70052
Impact of the Race-Neutral Equation on Mortality Risk Prediction in Korean Patients With Chronic Obstructive Pulmonary Disease
Abstract
Background and objective: Recently, GLI-2022, a race-neutral reference equation, was proposed for spirometric interpretation. However, the impact of using the GLI-2022 in predicting mortality risk has not been fully investigated. This study determined whether the GOLD grades based on GLI-2022 or race-specific equations are overestimated or underestimated in terms of mortality risk prediction among Korean patients with COPD.
Methods: The participants were enrolled in a prospective COPD cohort study conducted between 2005 and 2022. Patients were classified into GOLD 1 to GOLD 4 based on the post-bronchodilator forced expiratory volume in 1 s (FEV1) % predicted using the GLI-2022, GLI Northeast Asian (GLI-2012), Choi's, and KNHANES-VI reference equations. The risk of all-cause mortality was compared between GOLD grades calculated using different equations.
Results: Among 1989 patients with COPD, 336 died during a median follow-up of 5.0 years (interquartile range, 3.1-7.3). The GLI-2022 estimated FEV1% predicted lower than those of GLI-2012, Choi's, and KNHANES-VI. No differences were found in the discrimination or calibration between the mortality prediction models. Rather, the GLI-2022 equation discriminated the mortality risk between the GOLD 1 and GOLD 2 groups (adjusted hazard ratio [aHR], 1.46; 95% confidence interval [CI], 1.05-2.03); however, the race-specific equations did not (Choi's: aHR, 1.22; 95% CI, 0.80-1.85; KNHANES-VI: aHR, 1.19; 95% CI, 0.77-1.82).
Conclusion: Our results suggest that race-specific equations may overestimate the severity of airflow obstruction in Korean patients with mild COPD, which supports the new recommendation for the use of the GLI-2022.
Keywords: chronic obstructive pulmonary disease; forced expiratory volume; prognosis; prospective studies.
© 2025 Asian Pacific Society of Respirology.
References
-
- M. R. Becklake and N. White, “Sources of Variation in Spirometric Measurements. Identifying the Signal and Dealing With Noise,” Occupational Medicine 8 (1993): 241–264.
-
- “Lung Function Testing: Selection of Reference Values and Interpretative Strategies. American Thoracic Society,” American Review of Respiratory Disease 144 (1991): 1202–1218.
-
- M. J. Hegewald and R. O. Crapo, “Socioeconomic Status and Lung Function,” Chest 132 (2007): 1608–1614.
-
- D. Van Sickle, S. Magzamen, and J. Mullahy, “Understanding Socioeconomic and Racial Differences in Adult Lung Function,” American Journal of Respiratory and Critical Care Medicine 184 (2011): 521–527.
-
- N. W. Schluger, A. J. Dozor, and Y. E. G. Jung, “Rethinking the Race Adjustment in Pulmonary Function Testing,” Annals of the American Thoracic Society 19 (2022): 353–356.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
